晚期非鳞非小细胞肺癌一线诱导化疗后贝伐单抗联合培美曲塞维持治疗的疗效和安全性 |
评价者:刘晓晴 |
Efficacy and Safety of Maintenance Bevacizumab Combined with Pemetrexed after First-Line Induction Chemotherapy in Advanced Nonsquamous Non-Small Cell Lung Cancer |
图1 两药维持治疗组和贝伐单抗维持治疗组PFS和OS比较 |